90460

Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered

The CPT code 90460 represents the administration of an immunization to a pediatric or adolescent patient (through 18 years of age) via any route (intramuscular, subcutaneous, oral, or intranasal). A critical distinguishing factor of this code is that it requires face-to-face counseling by a physician or another qualified health care professional (QHP) to the patient or the patient's family regarding the vaccine. This code is utilized specifically for the first or the only component of each vaccine or toxoid administered during the encounter. A component is defined as each antigen in a vaccine that prevents disease caused by one organism. For example, a single-antigen vaccine like the seasonal influenza vaccine contains one component, whereas a combination vaccine like MMR (Measles, Mumps, Rubella) contains three distinct components. When a combination vaccine is administered, 90460 is reported for the first component, and the add-on code 90461 is reported for each additional component. The service encompasses the full spectrum of immunization delivery: reviewing the patient's immunization history, assessing contraindications and allergies, providing the Vaccine Information Statement (VIS), discussing the risks and benefits of the vaccine, answering any questions from the parent or guardian, preparing the vaccine dose, safely administering the vaccine utilizing the appropriate technique and anatomical site, and observing the patient for any immediate adverse reactions or anaphylaxis. Proper documentation must reflect the specific vaccine administered, the route, the anatomical site, the publication date of the VIS provided, and the specific counseling performed by the physician or QHP. If counseling is not performed by a physician or QHP (for instance, if administered by a medical assistant without QHP counseling), alternative immunization administration codes (such as 90471 through 90474) must be utilized instead, regardless of the patient's age. It is also important to note that the vaccine product itself must be reported separately using the appropriate CPT code for the specific toxoid or vaccine formulation. Furthermore, understanding the definition of a component is critical for accurate reporting. The term component refers to each antigen in a vaccine that prevents disease caused by one organism. Combination vaccines contain multiple vaccine components. By accurately distinguishing between single-component and multi-component vaccines, coders ensure proper utilization of the base administration code 90460 alongside the add-on code 90461. This level of granularity supports accurate reimbursement for the additional clinical work, counseling, and overhead involved in administering complex immunizations to pediatric and adolescent populations while maintaining strict adherence to current procedural terminology guidelines.

Clinical Indications

  • Routine pediatric and adolescent immunization schedules (e.g., DTaP, MMR, Varicella, Polio, HPV, Meningococcal).
  • Seasonal vaccine administration, such as the annual influenza vaccine or updated COVID-19 vaccines, for patients under 19 years old.
  • Catch-up vaccination schedules for children or adolescents who are behind on their standard immunization series.
  • Post-exposure prophylaxis requiring active immunization (e.g., Hepatitis B, Rabies, or Tetanus toxoid) in pediatric patients.
  • Travel-specific immunizations (e.g., Typhoid, Yellow Fever) for pediatric patients preparing for international travel.

Procedure Steps

  1. The physician or qualified healthcare professional reviews the patient's comprehensive medical and immunization history.
  2. Assess the patient for any contraindications, precautions, or severe allergies related to the vaccine components.
  3. Provide the current Vaccine Information Statement (VIS) to the patient, parent, or legal guardian.
  4. Engage in face-to-face counseling, discussing the benefits, potential side effects, and risks of the specific vaccine, and answer any questions.
  5. Obtain informed consent from the parent, guardian, or patient (if of appropriate age).
  6. Prepare the vaccine product using aseptic technique, verifying the correct formulation, dosage, and expiration date.
  7. Administer the vaccine via the appropriate route (e.g., intramuscular injection in the deltoid or anterolateral thigh, subcutaneous injection, oral drops, or intranasal spray).
  8. Observe the patient for a post-administration period to monitor for acute adverse reactions, such as syncope or anaphylaxis.
  9. Document the vaccine details (lot number, manufacturer, expiration date), site and route of administration, VIS given, and the counseling provided in the medical record.

Coding Guidelines

  • Use 90460 for patients through 18 years of age (i.e., up to the 19th birthday). For patients 19 years or older, use 90471-90474.
  • Counseling by a physician or other qualified health care professional (QHP) is mandatory. If no QHP counseling is provided, use 90471-90474.
  • Report 90460 for the first or only component of EACH vaccine administered. A component refers to each disease-preventing antigen in the vaccine.
  • For combination vaccines (e.g., MMR, DTaP), report 90460 for the first component and the add-on code 90461 for each additional component in that specific combination vaccine.
  • Do not append modifier 51 (Multiple Procedures) to 90460.
  • The vaccine or toxoid product itself must be reported separately using the appropriate CPT code (90476-90750).
  • If an Evaluation and Management (E/M) service is performed at the same visit, it must be significant and separately identifiable to be reported with modifier 25.

Associated ICD-10 Codes